Takeda Pharmaceutical Co. Ltd. is beefing up its presence in emerging markets and in Europe by paying $13.7 billion in cash for Nycomed GmbH, a privately held mid-sized pharma company.

Clavis Pharma ASA has gained a small equity stake in Translational Therapeutics Inc. in return for out-licensing its modified version of the antiviral drug ribavirin for applications in cancer. (BioWorld International)

Shares in Orexo AB dipped 10 percent last week on news that the company was seeking SEK250 million (US$40.1 million) in a discounted rights offering directed at existing shareholders and convertible bond holders.